No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
AVTR240726C30000
- 0.05
- -0.01-16.67%
15min DelayClose Jul 22 15:59 ET
0.06High0.05Low
0.06Open0.06Pre Close11 Volume0 Open Interest30.00Strike Price56.00Turnover176.24%IV42.48%PremiumJul 26, 2024Expiry Date0.00Intrinsic Value100Multiplier3DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type0.0347Delta0.0197Gamma421.80Leverage Ratio-0.0307Theta0.0001Rho14.63Eff Leverage0.0017Vega
Intraday
- 5D
- Daily
News
Avantor (AVTR) Gets a Buy From J.P. Morgan
Analysts Estimate Avantor, Inc. (AVTR) to Report a Decline in Earnings: What to Look Out for
Express News | Avantor Inc : Bernstein Cuts Target Price to $22 From $23
NIH Outlays Rise by 5% in June, Says Baird
Avantor Is Maintained at Outperform by RBC Capital
Avantor Is Maintained at Outperform by RBC
Avantor Price Target Raised to $31.00/Share From $30.00 by RBC Capital
Avantor Price Target Raised to $31.00/Share From $30.00 by RBC
Comments
A low ROE and high debt usage is unattractive. High quality businesses can achieve high ROE without debt. If two companies have equal ROE, the less indebted one is preferred.
Should We Be Cautious About Avantor, Inc.'s (NYSE:AVTR) ROE Of 6.1%? 2
Avantor's high P/E is buoyed by investor expectations of robust future growth and an outstanding earnings outlook, supported by mid-term rates of earnings growth. As long as conditions hold, these factors will sustain the stock’s price.
Avantor remains good investment as it is undervalued offering future growth prospects. Despite market risks and volatility, investors are urged to consider other factors like company's balance sheet strength before deciding.
Avantor's low ROE, despite leverage usage, is not an appealing investment. Reliance on fiscal leverage especially during uncertain credit market conditions could pose higher risk. Consider the company's performance without borrowing abilities.
Here are the top gap ups and downs for the stocks with a market cap above $5 billion after market closed (gaps range from large to small):
Gap Ups
1. $Reata Pharmaceuticals(RETA.US$ +54.02%
2. $Roku Inc(ROKU.US$ +31.41%
3. $TAL Education(TAL.US$ +24.42%
4. $XPeng(XPEV.US$ +15.68%
5. $Bilibili(BILI.US$ +15.25%
6. $iQIYI(IQ.US$ +13.26%
7. $SkyWest(SKYW.US$+12.33%
Gap Downs
1. $Enphase Energy(ENPH.US$ -0.15%
2. $Juniper Networks(JNPR.US$ -6.94% ...
Gap Ups
1. $Reata Pharmaceuticals(RETA.US$ +54.02%
2. $Roku Inc(ROKU.US$ +31.41%
3. $TAL Education(TAL.US$ +24.42%
4. $XPeng(XPEV.US$ +15.68%
5. $Bilibili(BILI.US$ +15.25%
6. $iQIYI(IQ.US$ +13.26%
7. $SkyWest(SKYW.US$+12.33%
Gap Downs
1. $Enphase Energy(ENPH.US$ -0.15%
2. $Juniper Networks(JNPR.US$ -6.94% ...
+10
26
5
Read more